1. Home
  2. OGN vs SGRY Comparison

OGN vs SGRY Comparison

Compare OGN & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.72

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Surgery Partners Inc.

SGRY

Surgery Partners Inc.

BUY

Current Price

$13.33

Market Cap

1.6B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
OGN
SGRY
Founded
1923
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
OGN
SGRY
Price
$13.72
$13.33
Analyst Decision
Hold
Buy
Analyst Count
5
12
Target Price
$11.25
★ $18.82
AVG Volume (30 Days)
1.9M
★ 2.2M
Earning Date
11-09-2026
11-09-2026
Dividend Yield
★ 0.58%
N/A
EPS Growth
N/A
★ 54.14
EPS
★ 0.95
N/A
Revenue
★ $6,216,000,000.00
$1,145,438,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.51
N/A
P/E Ratio
$14.43
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.69
$11.41
52 Week High
$13.79
$23.44

Technical Indicators

Market Signals
Indicator
OGN
SGRY
Relative Strength Index (RSI) 53.70 43.26
Support Level $13.46 $13.26
Resistance Level $13.77 $15.02
Average True Range (ATR) 0.04 0.79
MACD -0.00 -0.05
Stochastic Oscillator 59.09 13.95

Price Performance

Historical Comparison
OGN
SGRY

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About SGRY Surgery Partners Inc.

Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.

Share on Social Networks: